ASHP to Testify at House Hearing on Compounding

Published Online: Tuesday, July 16, 2013

July 16, 2013--ASHP is scheduled to testify today at a congressional hearing on reforming the regulatory framework of pharmacy compounding.
Kasey K. Thompson, Pharm.D.,  M.S., ASHP vice president of policy, planning, and communications, will represent the Society at the hearing called by the Health Subcommittee of the House Energy and Commerce Committee.
ASHP members are encouraged to email their House of Representatives member and ask for support of compounding legislation that establishes a clear jurisdictional boundary between the FDA and state boards of pharmacy.
The hearing will be broadcast at 3:00 p.m. on the Committee's website.
Latest Articles
Donnie Calhoun, RPh, PD, National Community Pharmacists Association (NCPA) Foundation vice president, discusses how pharmacists can prepare themselves and their business before, during, and after a disaster.
Ken Whittemore Jr, Surescript's senior vice president of professional and regulatory affairs, talks about some new transactions available that can help pharmacists.
In case you got caught up in the Thanksgiving holiday rush, here are the top trending stories you may have missed in November:
Bryan Ziegler, PharmD, executive director of Kennedy Pharmacy Innovation Center, provides some resources for community pharmacists to use when implementing new collaborative services with primary care providers.
Latest Issues